

Founded: 2018
Headquarters: Strasbourg, France
Product: CE‑marked digital biomarkers platform (brainTale-care)
Focus: White-matter measurement for neurological diagnosis, prognosis and monitoring
Recent funding: €4.5M round announced June 2023
Neurology — diagnosis, prognosis and monitoring via quantitative white-matter measurement
2018
Medtech / Digital health
€4.5M
Round announced to accelerate development and expansion in Europe; included business angels and support from Bpifrance Grand Est Deeptech plan
“Participation from regional investor Capital Grand Est, insurer MACSF, business angels, and support from Bpifrance Grand Est Deeptech plan”